Clinical Trial Update: Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors [NA]

View source ↗

Summary

The trial evaluating AuroLase Therapy for primary or metastatic lung tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• AuroLase Therapy

Snippet

Sponsor: Nanospectra Biosciences, Inc. | Conditions: Primary or Metastatic Lung Tumors | NA | Status: TERMINATED